-
Learn More About AvastinAvastin (bevacizumab) is the first FDA-approved drug that inhibits angiogenesis, or the formation of new blood vessels in support of tumor growth. -
The Cost of Avastin: Extending Life, Growing Genentech Stock Price?Avastin, with its cutting-edge ability to starve cancerous tumors by throttling their blood supply, is expected to be one of the world’s top-selling drugs. Its approval is viewed as a possible lowering in standards for approval of certain cancer drugs. Is it worth it?
-
Balancing Avastin's Potential and Problems: A Survivor's ThoughtsWhen the news broke December 5 that an FDA expert panel had voted 5-4 to reject Avastin (bevacizumab) as an approved breast cancer treatment because of serious side effects, I experienced a moment of deep sadness, as well as some frustration.












